Beryl Drugs Limited (BOM:524606)

Beryl Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 17, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	97	107	149	62	53	34
Market Cap Growth	-28.23%	-28.23%	141.20%	16.36%	58.09%	81.10%
Enterprise Value	129	150	194	106	85	72
Last Close Price	19.10	21.05	29.33	12.16	10.45	6.61
PE Ratio	16.75	18.44	19.35	8.05	-	13.99
PS Ratio	0.46	0.51	0.56	0.23	0.36	0.24
PB Ratio	1.02	1.12	1.67	0.77	0.73	0.42
P/TBV Ratio	1.02	1.12	1.67	0.77	0.73	0.42
P/FCF Ratio	21.45	23.64	-	7.45	-	-
P/OCF Ratio	3.67	4.05	18.14	2.58	-	9.90
EV/Sales Ratio	0.61	0.71	0.73	0.40	0.58	0.51
EV/EBITDA Ratio	4.90	5.69	7.34	4.77	15.35	4.43
EV/EBIT Ratio	9.28	10.77	13.43	7.52	-	20.77
EV/FCF Ratio	28.67	33.28	-	12.81	-	-
Debt / Equity Ratio	0.43	0.43	0.57	0.56	0.73	0.65
Debt / EBITDA Ratio	1.54	1.54	1.93	2.04	9.60	3.17
Debt / FCF Ratio	9.02	9.02	-	5.49	-	-
Asset Turnover	1.26	1.26	1.53	1.52	0.80	0.79
Inventory Turnover	6.05	6.05	9.72	7.24	3.27	4.44
Quick Ratio	1.46	1.46	1.36	1.25	0.79	0.85
Current Ratio	2.10	2.10	1.78	1.64	1.24	1.24
Return on Equity (ROE)	6.28%	6.28%	9.05%	9.97%	-8.66%	3.08%
Return on Assets (ROA)	5.21%	5.21%	5.16%	4.99%	-1.83%	1.21%
Return on Capital (ROIC)	6.32%	6.32%	6.78%	7.00%	-2.61%	1.66%
Return on Capital Employed (ROCE)	12.00%	12.00%	12.30%	12.60%	-	3.30%
Earnings Yield	5.98%	5.42%	5.17%	12.42%	-12.43%	7.15%
FCF Yield	4.66%	4.23%	-3.57%	13.42%	-16.68%	-39.77%
Buyback Yield / Dilution	-0.13%	-0.13%	-	-	0.01%	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.